News
Asthma drug shows promise in treating diabetes, obesity
Amlexanox, a drug prescribed for asthma in Japan, also reverses obesity, diabetes and fatty liver in mice, according to a new study by US researchers. "One of the reasons that diets are so ineffective...
News
Compound stimulates tumor-fighting protein in cancer therapy
A compound that stimulates the production of a tumor-fighting protein may improve the usefulness of the protein in cancer therapy, according to a team of researchers. TRAIL is a natural anti-tumor protein that suppresses tumor development during immune...
News
Fighting fat with fat: Stem cell discovery identifies potential obesity treatment
Ottawa scientists have discovered a trigger that turns muscle stem cells into brown fat, a form of good fat that could play a critical role in the fight against obesity. The findings from Dr. Michael Rudnicki's lab, based...
News
Low vitamin D levels may increase risk of Type 1 diabetes
Having adequate levels of vitamin D during young adulthood may reduce the risk of adult-onset type 1 diabetes by as much as 50%, according to researchers at Harvard School of Public Health (HSPH). The findings,...
News
Shire Reaches Agreement in Principle With U.S. Government
Shire plc , today announced that it has reached an agreement in principle to resolve the previously disclosed civil investigation into Shire's U.S. sales and marketing practices relating to ADDERALL XR®, VYVANSE® and DAYTRANA®.  ...
News
GSK response to news article in The Guardian on UK legal proceedings related to Avandia
Responding to a news article in The Guardian on UK legal proceedings related to our type 2 diabetes medicine Avandia (rosiglitazone), we would like to make the following points: We have every sympathy for people with health complications...
News
Discrepant analyses of industry-sponsored clinical trials
Internal pharmaceutical company documents detailing the planned and completed analyses for clinical trials do not always match the publically available report of the completed trial, highlighting a concerning lack of transparency, according to a study published in this...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read